HSY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
HSY is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 who is impatient and wants to act now. The stock has solid fundamentals and a decent Q1 beat, but the technical setup is weak and analyst sentiment has been drifting more cautious with repeated target cuts. My direct view is HOLD, not BUY, until price and trend improve.
HSY is in a short-term weak technical position. The MACD histogram is negative at -0.198, showing bearish momentum, though it is contracting, which suggests selling pressure may be easing. RSI_6 at 29.35 is near oversold levels, but not yet a clear reversal signal. Moving averages are converging, implying a possible inflection, but the stock is still below the pivot at 188.856 and trading near support at 183.421. Current pre-market price is 186, which is above S1 but still below the pivot, so the setup is neutral-to-bearish rather than a clean entry.
["Q1 2026 revenue rose 10.65% YoY to 3.10B.", "Net income jumped 94.07% YoY, showing strong earnings recovery.", "Gross margin improved to 39.39%, indicating better profitability.", "News flow highlighted strong Easter sales and a sales boost in mints and gum from GLP-1-related demand.", "The company beat Q1 earnings estimates and kept its full-year outlook unchanged.", "Options positioning is mildly constructive with call interest above put interest."]
["Multiple analysts lowered price targets in late April, signaling weaker near-term conviction.", "BofA, JPMorgan, Barclays, UBS, Deutsche Bank, and others are generally Neutral/Hold or equivalent.", "Management kept the full-year outlook unchanged, which the market interpreted as cautious.", "Commodity and input cost pressure remains a concern, especially cocoa and broader food costs.", "MACD remains negative and the stock is below the key pivot level.", "Hedge funds and insiders are both neutral, with no meaningful accumulation signal."]
Latest quarter: Q1 2026. Hershey posted strong top-line and margin improvement, with revenue up 10.65% YoY to 3.10B and gross margin up to 39.39%. Net income increased sharply to 435.1M, up 94.07% YoY, showing better operating leverage. The main weakness is that EPS was reported as 0 in the provided data, which appears inconsistent with the strong net income print, but the broader takeaway is that Q1 was materially better on revenue and profitability.
Analyst sentiment has turned more cautious over the past month, with several firms cutting price targets: BofA to 220, Morgan Stanley to 227, Stifel to 215, JPMorgan to 211, Barclays to 225, DA Davidson to 230, Deutsche Bank to 196, and UBS to 215. Most ratings remain Neutral/Hold, while Morgan Stanley stays Overweight. The wall street view is mixed but leans cautious: pros include stable brand strength, cash generation, and improving margins; cons include weak volume growth, input cost pressure, valuation contraction, and concerns that the current setup does not justify a more bullish stance.
